Skip to content

FO Medical & Biomedical Cluster

Created: 2026-04-06 (Session 31)

Overview

Flight Opportunities has funded ~20 medical and biomedical technology projects, testing devices and protocols for spaceflight medicine, surgical systems, physiological monitoring, and biomedical research tools in microgravity. This cluster represents ~5% of the FO portfolio by project count but has outsized research impact — generating peer-reviewed publications, clinical protocols, and patents.

Key pattern: Medical FO projects overwhelmingly produce research outcomes (publications, protocols, patents) rather than commercial products. Only one (Henry Ford ultrasound) achieved widespread clinical adoption. The gap between "validated in microgravity" and "deployed on ISS or commercialized" is wider for medical devices than for any other FO technology category — likely because FDA/regulatory pathways for space medical devices don't exist, and the market (astronaut healthcare) is tiny.

Projects by Outcome Category

Clinical/Protocol Impact (2 projects)

ID Organization Technology TRL Impact KB Page
94139 Henry Ford Health System Microgravity Health Care (ultrasound) 4→8 ISS ultrasound protocols adopted; global telemedicine impact henry-ford-health.md
93962 Massachusetts General Hospital NINscan 4a Cerebral Hemodynamics 4→7 NINscan-SE in Epilepsy Foundation wiki; 4+ publications mgh-ninscan.md

Henry Ford is the exemplar. PI Scott Dulchavsky adapted musculoskeletal ultrasound for ISS crew health monitoring. The protocols were adopted by NASA for on-orbit use and then transferred to remote/austere medicine on Earth — a rare FO example of spaceflight technology improving terrestrial healthcare. TRL 4→8 is the highest in this cluster.

MGH NINscan produced a portable near-infrared cerebral hemodynamics monitor. The simplified version (NINscan-SE) was picked up by the Epilepsy Foundation — a non-obvious clinical translation from spaceflight to neurology.

Research Publication Impact (5 projects)

ID Organization Technology TRL Publications KB Page
93937 UT Southwestern Medical Center Intracranial Pressure in Microgravity 6→7 4+ papers (J Physiol, JAMA Ophthalmology); LBNP sleeping bag; VIIP/SANS ut-southwestern-icp.md
106657 IMEC USA Electrophysiology of Neuronal Networks 5→7 npj Microgravity (Nature) 2025; VGLUT alteration finding imec-usa-neuropixels.md
106660 IMEC USA Lens-Free Imaging Microscope 6→7 Companion to [106657]; holographic microscopy in μg imec-usa-neuropixels.md
12195 Johns Hopkins University Vestibulo-ocular Function 4→6 Patent US9072481; "Advanced To" outcome; PI Shelhamer (no full page)
93852 Johnson Space Center Autonomous Cell Culture (3D tissues) 4→6 3D cell culture for radiation biology; PI Zarana Shavers (no full page)

UT Southwestern ICP is the highest-impact research project. PI Benjamin Levine's work on intracranial pressure and VIIP/SANS (Spaceflight-Associated Neuro-ocular Syndrome) produced foundational papers on why astronauts' vision deteriorates in space. The lower-body negative pressure (LBNP) sleeping bag countermeasure has terrestrial applications for traumatic brain injury patients.

IMEC brought semiconductor-industry neuropixel probes to microgravity on Blue Origin New Shepard (Dec 2023) and discovered VGLUT alteration in human neurons — published in Nature's npj Microgravity in 2025. This is the kind of fundamental science finding that justifies suborbital research access.

Surgical Systems — Active Research Pipeline (4 projects)

ID Organization Technology TRL Status KB Page
71954 Univ. of Louisville Aqueous Immersion Surgical System 4→6 10-year multi-institution program; patent US11540858; TRL7 on VG SpaceShipTwo 2021 uofl-aqueous-surgery.md
91363 Univ. of Louisville Hermetic Surgery System 4→7 Continuation of [71954]; PI Pantalos; 25-page final report uofl-aqueous-surgery.md
12196 Orbital Medicine, Inc. Medical Chest Drainage System 4→6 Proof of concept only; no ISS deployment orbital-medicine.md
71978 Orbital Medicine, Inc. Evolved Medical Microgravity Suction Device 4→6 EMMSD flew Blue Origin New Shepard Dec 2017 orbital-medicine.md

The surgical arc is the most sustained effort in this cluster — spanning 2010–2024 across UofL, Cornell, CMU, Orbital Medicine, and Purdue. The core challenge: how do you perform surgery in microgravity when blood and fluids float? UofL's aqueous immersion approach (submerging the surgical field in saline) is the most mature solution, with a patent and TRL7 validation on SpaceShipTwo.

Additional surgical/suction projects: - 106655 Purdue: Medical suction + surgical facility (4→6) — integrates UofL and Orbital Medicine work - 155246 UofL: Dehydrated red blood cells for transfusion (5→7) — ambient-temperature blood storage for space; dual-use military/space application

Enabling Devices (2 projects)

ID Organization Technology TRL Impact KB Page
106717 Mayo Clinic — Jacksonville ATOM Biological Sampling 4→6 Enabled Zubair's ISS stem cell program (NASA Exceptional Scientific Achievement Medal) mayo-clinic-atom.md
91423 Glenn Research Center In-Flight Lab Analysis 4→4 Zero TRL gain; biomedical point-of-care (no full page)

Mayo Clinic ATOM is a quiet success story. The Automated Tissue preservation and Operations in Microgravity device itself didn't commercialize, but it enabled Abba Zubair's groundbreaking ISS stem cell research that earned a NASA Exceptional Scientific Achievement Medal. The FO contribution was infrastructure, not the science itself.

Physiological Monitoring — No Commercial Follow-on (3 projects)

ID Organization Technology TRL Outcome KB Page
12203 The Vital Space Team Non-Invasive Physiologic Monitoring 4→6 PI Komatireddy pivoted to consumer digital health (Daytona Health, Motiv Labs) vital-space-team.md
106665 UC Davis CHANGES Human Adaptation 4→6 Sensorimotor and physiological adaptation study; feeds long-duration health models (no full page)
12253 Stanford University Non-Invasive Hemodynamic Monitoring 4→6 PI Kovacs; cardiac bioimpedance in microgravity; "Advanced To" 2014 (no full page)

The Vital Space Team is the most interesting case: PI Ravi Komatireddy took the wearable monitoring concept from FO and pivoted to consumer digital health. The technology didn't go to space — it went to market. But through a different door than FO intended.

Active / Too Early to Assess (2 projects)

ID Organization Technology TRL Status KB Page
184148 Ecoatoms, Inc. HERMES Automated Genetic Extraction 4→9 TechLeap Prize winner; summer 2026 flight target ecoatoms.md
12206 Univ. of Washington Activity Monitoring Parabolic Flight 5→7 PI Cavanagh; bone health monitoring; NSBRI-funded (no full page)

Cluster Statistics

Metric Value
Total medical/biomedical projects ~20 (across ~17 TechPort IDs)
% of FO portfolio ~5%
Clinical/protocol adoption 2 projects (Henry Ford, MGH)
Peer-reviewed publications 10+ papers across cluster
Patents filed 2 (UofL US11540858, JHU US9072481)
Commercial products 0
Tracked funding Minimal — most are academic/center-funded
Mean TRL gain +1.8 (slightly above portfolio average of +1.7)

Cross-Cutting Themes

1. The ISS Gap

Most medical FO projects aim for ISS deployment as the next step after suborbital validation. But the gap between "validated on parabolic/suborbital flight" and "operating on ISS" is enormous — requiring safety reviews, crew training, upmass allocation, and integration with ISS systems. No medical device from the FO pipeline has a confirmed ISS deployment via the FO pathway alone (Henry Ford's ultrasound protocols were adopted through a separate ISS medical operations channel).

2. Research vs. Product Outcomes

Medical technologies from FO produce knowledge (publications, protocols, datasets) rather than hardware products. This is appropriate — FO's role for medical projects is providing microgravity access for research, not building commercial medical devices. But it means FO's impact metrics for this cluster should emphasize publications and protocol adoption, not TRL advancement or revenue.

3. Dual-Use Potential

Several projects have terrestrial applications: - UT Southwestern LBNP sleeping bag → traumatic brain injury - Henry Ford ultrasound → remote/austere telemedicine - UofL dehydrated RBCs → military field blood supply - Vital Space Team → consumer digital health (PI pivot)

The dual-use path may be more promising than the spaceflight path for commercialization.

4. PI Networks

The surgical arc shows strong PI continuity: George Pantalos (UofL) appears across multiple projects and institutions. Similarly, the IMEC projects are PI-driven (same team, two complementary instruments on the same flight). Medical FO projects cluster around individual investigators more than any other technology area.

Comparison to Other Clusters

Cluster Projects Commercial Outcomes Acquisitions Research Outcomes
Medical/Biomedical ~20 0 0 10+ papers, 2 patents, ISS protocols
Precision Landing (JPL/Draper) 5 0 0 Mars 2020, CLPS missions
Launch Vehicle (SpaceX, Astra, UP) ~10 3+ 1 Minimal
UCF Regolith 13+ 0 0 Extensive

Medical is the highest-publication, lowest-commercial cluster in the FO portfolio. This is consistent with the academic/clinical composition — no commercial companies in this cluster except Orbital Medicine (which never commercialized) and Ecoatoms (too early).